No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ICLR240719C210000
- 76.00
- 0.000.00%
15min DelayTrading Dec 13 15:49 ET
0.00High0.00Low
0.00Open76.00Pre Close0 Volume1 Open Interest210.00Strike Price0.00Turnover77.72%IV-9.78%PremiumJul 19, 2024Expiry Date107.00Intrinsic Value100Multiplier17DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9942Delta0.0003Gamma2.94Leverage Ratio-0.0533Theta0.0994Rho2.93Eff Leverage0.0114Vega
Intraday
- 5D
- Daily
News
Deutsche Bank's Fresh Money List for 3Q
ICON Plc Schedules Second Quarter 2024 Earnings Conference Call
ICON plc (NASDAQ:ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on
Should Weakness in ICON Public Limited Company's (NASDAQ:ICLR) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
ICON (NASDAQ:ICLR) has had a rough three months with its share price down 6.8%. But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean t
Is Icon PLC (ICLR) a Solid Growth Stock? 3 Reasons to Think "Yes"
Barclays Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $355
Barclays analyst Luke Sergott maintains $Icon PLC(ICLR.US)$ with a buy rating, and maintains the target price at $355.According to TipRanks data, the analyst has a success rate of 39.9% and a total av
Here's Why Icon PLC (ICLR) Is a Strong Momentum Stock
Comments
While ICON's earnings forecast dipped slightly, the consensus price target remains unchanged. Despite the slower expected revenue growth, ICON is still predicted to outperform the wider industry growth.
ICON Public Limited Company (NASDAQ:ICLR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
$AbbVie(ABBV.US$ $Align Technology(ALGN.US$ $Armata Pharmaceuticals(ARMP.US$ $Ault Alliance(AULT.US$ $Becton Dickinson & Co(BDX.US$ $Carmell(CTCX.US$ $Edwards Lifesciences(EW.US$ $National Vision(EYE.US$ $Icon PLC(ICLR.US$ $Lam Research(LRCX.US$ $Molina Healthcare(MOH.US$ $Impinj(PI.US$ $Rimini Street(RMNI.US$ $Silicon Motion Technology(SIMO.US$ $United Rentals(URI.US$ $Warrantee(WRNT.US$
2
Upgrades
• $Marqeta(MQ.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $Northwest Natural(NWN.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $Otis Worldwide(OTIS.US$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $Snowflake(SNOW.US$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $Eaton(ETN.US$ : Barclays Downgrades to Underweight from Eq...
• $Marqeta(MQ.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $Northwest Natural(NWN.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $Otis Worldwide(OTIS.US$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $Snowflake(SNOW.US$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $Eaton(ETN.US$ : Barclays Downgrades to Underweight from Eq...
12
1
Upgrades
• $Aptiv PLC(APTV.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $112 (from $108)
• $ASM INTERNATIONAL NV SPON ADR EACH REP 1 ORD SHS(ASMIY.US$ : Barclays Upgrades to Overweight from EqualWeight - PT $425 (from $300)
• $Brighthouse Financial(BHF.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $54 (from $53)
• $Cardinal Health(CAH.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $74 (from $54)
• $CrowdStrike(CRWD.US$ : Goldman...
• $Aptiv PLC(APTV.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $112 (from $108)
• $ASM INTERNATIONAL NV SPON ADR EACH REP 1 ORD SHS(ASMIY.US$ : Barclays Upgrades to Overweight from EqualWeight - PT $425 (from $300)
• $Brighthouse Financial(BHF.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $54 (from $53)
• $Cardinal Health(CAH.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $74 (from $54)
• $CrowdStrike(CRWD.US$ : Goldman...
11
1
Read more